MDL Track
MDL 2738
D.N.J.
Johnson & Johnson talcum powder products liability
67,115 pending
Pharmaceutical · claims alleging talc products contributed to ovarian cancer or mesothelioma
Defendant
Johnson & Johnson
MDL / Track
MDL 2738
D.N.J.
Judge
Judge Michael A. Shipp
Plaintiffs
~67,358 pending (67,115 per JPML's March 2, 2026 report, plus ~243 new filings tracked since)
Bellwether / Trial
Settlement Status
Track litigations for free. Save this matter, capture notes, and monitor live signals.
Case overview
Johnson & Johnson reached a $5.5 billion global settlement on July 27, 2026 resolving 76,000 talcum powder claims—99.75% of all pending litigation—after U.S. Magistrate Judge Rukhsanah Singh granted J&J's motion to show cause why the remaining MDL 2738 cases should not be dismissed. The settlement, negotiated by plaintiffs' counsel Christopher Seeger, R. Bryant McCulley, and Hunter Shkolnik, follows the withdrawal of plaintiffs' two key specific causation experts from bellwether trials and caps fifteen years of litigation that included three failed bankruptcy attempts and verdicts reaching $1.5 billion.
Causation Theory
Plaintiffs allege two distinct mechanisms of harm: (1) asbestos-contaminated talc causing mesothelioma through inhalation or ingestion, supported by internal J&J documents dating to 1973 detecting chrysotile asbestos and tremolite in talc supplies, FDA testing in October 2019 that found trace chrysotile asbestos in a commercial lot, and the IARC's classification of asbestos as a known human carcinogen; and (2) perineal talc use causing epithelial ovarian cancer through particle migration to the ovaries triggering chronic inflammation, with the IARC classifying perineal talc use as "probably carcinogenic to humans" (Group 2B). The causation theory for ovarian cancer suffered a procedural blow when plaintiffs withdrew their specific causation experts after acknowledging competing risk factors and idiopathic cancer rates in bellwether case testimony.
Case Management Orders
Litigation status
Johnson & Johnson announced a $5.5 billion settlement July 27, 2026, to resolve approximately 76,000 ovarian cancer claims across MDL-2738 and state courts. The deal follows a July 22, 2026 order by Magistrate Judge Rukhsanah L. Singh requiring plaintiffs to show cause why remaining claims should not be dismissed after plaintiffs withdrew two specific-causation experts. District Judge Michael A. Shipp presides over MDL-2738 in the District of New Jersey. The settlement requires 95% participation to take effect.
MDL Track
MDL 2738
D.N.J.
Johnson & Johnson talcum powder products liability
67,115 pending
State Court Activity
Substantial parallel dockets in Missouri, California, Pennsylvania, New Jersey state courts; settlement covers state and federal claims
MDL 2738 Leadership
Plaintiff Leadership
Co-Lead Counsel
Liaison Counsel
Executive Committee Member
Steering Committee Member
Sindhu S. Daniel
Baron & Budd, P.C.
Jeff S. Gibson
Cohen & Malad, LLP
Victoria Maniatis
Sanders Phillips Grossman, LLC
Geographic exposure
KCIC Consulting 2025 report: talc filings surged 47% year-over-year — sharpest single-year increase on record. Talc-only claims now 9% of all asbestos filings. 40% of 2025 mesothelioma filings included talc exposure claim (up from 16% in 2019). Talc-only mesothelioma plaintiffs 57% women, average age 67–69 vs. 76 for traditional asbestos plaintiffs. IARC reclassified talc as Group 2A ('probably carcinogenic to humans') July 2024. FDA October 2019 testing detected chrysotile asbestos in single J&J Baby Powder lot, prompting voluntary recall.
MDL No. 2738 (In re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation) sits in U.S. District Court for the District of New Jersey. J&J headquartered in New Brunswick. January 2026 Special Master report found plaintiffs' causation experts reliable for trial testimony.
Jackson County saw August 2026 filing (KCTV5, Aug. 4, 2026) — 59-year-old plaintiff with 1976–2017 perineal use, diagnosed 2017, learned of talc-ovarian cancer link 2024. St. Louis historically produced large ovarian cancer verdicts.
Los Angeles, San Diego, Alameda County see thousands of filings. Death Valley (Briggs Talc Mine) documented by USGS 2004 as tremolite-contaminated.
Gouverneur, St. Lawrence County — R.T. Vanderbilt Co. and Gouverneur Talc Co. operations. NIOSH cohort documented excess mesothelioma; deposits contain 37–59% non-asbestiform tremolite plus asbestiform tremolite and anthophyllite per Finkelstein reanalysis.
Eastern Magnesia (later Carey-Canada) talc mining. NIOSH worker mortality cohort shows respiratory disease elevations. 1974 internal J&J report identified 'fibrous anthophyllite' and 'chrysotile asbestos' in Vermont talc supply as 'severe health hazard.'
Philadelphia launched mass tort program for talcum powder lawsuits with 2026 bellwether trials scheduled.
Cook County (Chicago) steady stream of mesothelioma and ovarian cancer claims.
August 2026: $25 million verdict ordered against J&J and successor entities for terminal peritoneal mesothelioma from lifelong baby powder use. Dr. Steve Mann deposition testimony revealed he made safety claims without reviewing test data, had seen asbestos-positive results but did not inform management or regulators.
2025: $8 million Boston verdict for mesothelioma linked to talc use.
2024: $260 million mesothelioma verdict upheld for talc-caused disease.
Key defendants
Johnson & Johnson
Role: Original Manufacturer
Core defendant in MDL No. 2738 (D.N.J.). Special Master granted motion to add successor entities as defendants in Jan. 2024 (Dkt. No. 26636).
LTL Management LLC
Role: Bankruptcy Vehicle
North Carolina LLC created Oct. 2021 to assume Old JJCI's talc liabilities. Subject of fraudulent transfer litigation (Bynum v. LLT Management LLC, No. 3:24-cv-07065-MAS-RLS).
Red River Talc LLC
Role: Successor Entity
Texas LLC created Aug. 2024 restructuring; holds talc claims and pursuing Chapter 11 settlement. Over 60,000 plaintiffs asserting claims as of Sept. 2024.
Kenvue Inc.
Role: Successor Entity
Added as defendant in Second Amended Master Complaint per Special Master Order No. 17 (Dkt. No. 26636). Successor liability exposure under multi-state choice-of-law analysis.
Janssen Pharmaceuticals Inc.
Role: Affiliate Defendant
Added as defendant in SAMC; same successor liability posture as Kenvue. Limited direct talc product involvement.
Imerys Talc America Inc.
Role: Talc Supplier
Named in First Amended Master Complaint. Mining/defense exposure distinct from consumer products defendants.
| Defendant | Role | Intelligence Note |
|---|---|---|
| Johnson & Johnson | Original Manufacturer | Core defendant in MDL No. 2738 (D.N.J.). Special Master granted motion to add successor entities as defendants in Jan. 2024 (Dkt. No. 26636). |
| LTL Management LLC | Bankruptcy Vehicle | North Carolina LLC created Oct. 2021 to assume Old JJCI's talc liabilities. Subject of fraudulent transfer litigation (Bynum v. LLT Management LLC, No. 3:24-cv-07065-MAS-RLS). |
| Red River Talc LLC | Successor Entity | Texas LLC created Aug. 2024 restructuring; holds talc claims and pursuing Chapter 11 settlement. Over 60,000 plaintiffs asserting claims as of Sept. 2024. |
| Kenvue Inc. | Successor Entity | Added as defendant in Second Amended Master Complaint per Special Master Order No. 17 (Dkt. No. 26636). Successor liability exposure under multi-state choice-of-law analysis. |
| Janssen Pharmaceuticals Inc. | Affiliate Defendant | Added as defendant in SAMC; same successor liability posture as Kenvue. Limited direct talc product involvement. |
| Imerys Talc America Inc. | Talc Supplier | Named in First Amended Master Complaint. Mining/defense exposure distinct from consumer products defendants. |
Timeline
First scientific finding: talc in ovarian tumors
Researchers publish first finding of talc particles embedded in ovarian tumors, establishing biological plausibility for talc-ovarian cancer link.
First plaintiff verdict in talc trial
South Dakota jury finds for plaintiff Deane Berg in Berg v. Johnson & Johnson, No. CIV-09-417, establishing that inadequate warnings could support liability, though no damages awarded.
First major damages verdict: $72 million
St. Louis jury awards $72 million to estate of Jacqueline Fox in Fox v. Johnson & Johnson, No. 1422-CC09312, first major damages verdict in talc litigation.
$4.69 billion verdict in Ingham
St. Louis jury awards $4.69 billion to 22 women in Ingham v. Johnson & Johnson, No. 1422-CC09312-01, largest talc verdict in history. Award reduced to $2.12 billion on appeal; upheld by U.S. Supreme Court June 1, 2021.
FDA finds asbestos in J&J Baby Powder
FDA announces detection of chrysotile asbestos in single lot of Johnson's Baby Powder purchased online. J&J voluntarily recalls approximately 33,000 bottles (lot 22318RB), first recall in product history.
First 'Texas Two-Step' bankruptcy: LTL Management
Johnson & Johnson creates LTL Management LLC to assume talc liabilities and files Chapter 11 bankruptcy, automatically staying approximately 38,000 lawsuits.
Third Circuit dismisses first LTL bankruptcy
Third Circuit dismisses LTL Management bankruptcy in In re LTL Management LLC, 58 F.4th 738, ruling filing made in bad faith; J&J's $61.5 billion funding agreement shows no genuine financial distress. Lawsuits resume.
Third bankruptcy attempt: Red River Talc
J&J creates Red River Talc LLC and files third Chapter 11 bankruptcy in Southern District of Texas, proposing $8-9 billion trust to resolve claims. Automatic stay reimposed on approximately 67,000 cases.
Red River Talc bankruptcy dismissed
Bankruptcy Judge Christopher Lopez dismisses Red River Talc LLC Chapter 11 case, Case No. 24-90505 (Bankr. S.D. Tex.), finding 'voting irregularities' and bad faith; returns approximately 67,115 cases to MDL 2738 before Judge Michael Shipp in District of New Jersey.
$5.5 billion global settlement
Johnson & Johnson announces settlement of 76,000 talcum powder lawsuits for at least $5.5 billion, resolving 99.75% of pending federal and state court claims. $3 billion payment scheduled for 2027. Settlement follows July 22 ruling by U.S. Magistrate Judge Rukhsanah Singh in MDL 2738 granting J&J motion to show cause after plaintiffs withdrew key specific causation experts.
Statute of limitations
MDL 2738 (In re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation) before Judge Michael A. Shipp in D.N.J. does not toll state statutes of limitations. J&J's third bankruptcy dismissal in early 2024 removed any stay on filings. As of January 6, 2026, 67,580 cases pending in MDL per source. No global settlement tolling agreement currently in effect—intake must screen by individual state SOL. Sources indicate statutes typically range 1–4 years from diagnosis or discovery, with wrongful death often shorter than personal injury.
California
2 years
Rule: Cal. Code Civ. Proc. § 335.1; discovery rule applies per sources
Discovery: Clock starts when plaintiff discovers or should have discovered injury and its cause; ovarian cancer diagnosis typically triggers
No pending revival statute identified in sources
Florida
4 years personal injury, 2 years wrongful death
Rule: Fla. Stat. § 95.11; discovery rule applies
Discovery: Clock begins when plaintiff knew or should have known of injury with reasonable diligence
Longest PI window among major states per source table; large plaintiff pool
New York
3 years personal injury, 2 years wrongful death
Rule: N.Y. C.P.L.R.; discovery rule applies
Discovery: Accrues upon discovery of injury and causal link
WD claims shorter than PI; significant state court filings per sources
Texas
2 years
Rule: Tex. Civ. Prac. & Rem. Code; discovery rule applies
Discovery: Accrues when plaintiff knows or should know of injury and cause
J&J bankruptcy maneuvers do not stay state SOL per sources
Pennsylvania
2 years
Rule: 42 Pa. Cons. Stat.; discovery rule applies
Discovery: Accrues when plaintiff knows or reasonably should know of injury and its cause
Active venue for talc filings per sources
New Jersey
2 years
Rule: N.J. Stat. Ann.; discovery rule applies
Discovery: Accrues upon discovery of injury and causal connection
MDL 2738 venued in D.N.J. but does not toll state SOL; state filings accelerating post-bankruptcy dismissal per January 2026 source
Illinois
2 years
Rule: 735 Ill. Comp. Stat.; discovery rule applies
Discovery: Accrues when plaintiff knows or reasonably should know of injury and its cause
Statute of repose may apply to older product use
Minnesota
4 years personal injury, 3 years wrongful death
Rule: Minn. Stat.; discovery rule applies
Discovery: Four-year filing period generally begins when illness is diagnosed per source
Longest PI SOL in Upper Midwest; WD shorter than PI per source
| State | SOL | Rule | Discovery Rule | Notes |
|---|---|---|---|---|
| California | 2 years | Cal. Code Civ. Proc. § 335.1; discovery rule applies per sources | Clock starts when plaintiff discovers or should have discovered injury and its cause; ovarian cancer diagnosis typically triggers | No pending revival statute identified in sources |
| Florida | 4 years personal injury, 2 years wrongful death | Fla. Stat. § 95.11; discovery rule applies | Clock begins when plaintiff knew or should have known of injury with reasonable diligence | Longest PI window among major states per source table; large plaintiff pool |
| New York | 3 years personal injury, 2 years wrongful death | N.Y. C.P.L.R.; discovery rule applies | Accrues upon discovery of injury and causal link | WD claims shorter than PI; significant state court filings per sources |
| Texas | 2 years | Tex. Civ. Prac. & Rem. Code; discovery rule applies | Accrues when plaintiff knows or should know of injury and cause | J&J bankruptcy maneuvers do not stay state SOL per sources |
| Pennsylvania | 2 years | 42 Pa. Cons. Stat.; discovery rule applies | Accrues when plaintiff knows or reasonably should know of injury and its cause | Active venue for talc filings per sources |
| New Jersey | 2 years | N.J. Stat. Ann.; discovery rule applies | Accrues upon discovery of injury and causal connection | MDL 2738 venued in D.N.J. but does not toll state SOL; state filings accelerating post-bankruptcy dismissal per January 2026 source |
| Illinois | 2 years | 735 Ill. Comp. Stat.; discovery rule applies | Accrues when plaintiff knows or reasonably should know of injury and its cause | Statute of repose may apply to older product use |
| Minnesota | 4 years personal injury, 3 years wrongful death | Minn. Stat.; discovery rule applies | Four-year filing period generally begins when illness is diagnosed per source | Longest PI SOL in Upper Midwest; WD shorter than PI per source |
Live intelligence
AI litigation brief
Talc remains late-stage / active trials with 427 current signals in the accepted feed.
Overview
Johnson & Johnson announced a $5.5 billion settlement July 27, 2026, to resolve approximately 76,000 ovarian cancer claims across MDL-2738 and state courts. The deal follows a July 22, 2026 order by Magistrate Judge Rukhsanah L. Singh requiring plaintiffs to show cause why remaining claims should not be dismissed after plaintiffs withdrew two specific-causation experts. District Judge Michael A. Shipp presides over MDL-2738 in the District of New Jersey. The settlement requires 95% participation to take effect.
Key developments
Trajectory
Court filings and press coverage are both active in MDL 2738, pointing to sustained litigation pressure rather than a one-off headline cycle. 6 live sources are contributing current context.
Editorial intelligence
MDL 2738 should stay on the lead docket watch because it is the primary consolidation vehicle for Talc.
Generated Aug 12, 2026, 2:00 AM UTC
427 events detected
Google News (171)
Money talcs: Why J&J offered $5.5bn to end cancer cases - RTE.ie
Johnson & Johnson To Settle Baby Powder Lawsuit Over A Decade Later - aol.com
Private-Label Body Powder Maker Files for Bankruptcy to Resolve Talc Lawsuits - WSJ
Vi-Jon files Chapter 11 bankruptcy to resolve legacy talc liabilities through $25M trust - The Business Journals
JNJ Stock Advances After Hours On $5.5B Proposal To Resolve Talc Litigation - Stocktwits
Missouri woman sues Johnson & Johnson, claims baby powder caused ovarian cancer - KCTV
Johnson & Johnson settlement: Does talcum powder really increase ovarian cancer risk? - The Indian Express
Beasley Allen Challenges Removal From Phila. Talc Litigation as Judge Defends Decision to Appeals Court - Law.com
Johnson & Johnson to pay out US$5.5bn in talc cancer case - The Chemical Engineer
J&J proposes $5.5 billion settlement deal for talc cancer lawsuits - chemistryworld.com
Beyond the US$5.5 billion settlement: what Johnson & Johnson’s talc litigation reveals about product liability - Lexology
Can J&J finally put the talc litigation behind it? - The Business Standard
Johnson & Johnson Proposes Comprehensive Settlement to End Ovarian Talc Litigation - Global Cosmetics News
Fear, science, and the law: If talc powder is unlikely to cause cancer and J&J was winning in court, why did it pay more than $5.5 billion to settle? - geneticliteracyproject.org
Johnson & Johnson (JNJ) Seeks $5.5 Billion Talc Lawsuit Settlement - Yahoo Finance
Johnson & Johnson agrees to pay billions in cancer lawsuit settlement - KTALnews.com
Johnson & Johnson offers US$5.5B to end ovarian cancer talc lawsuits - personalcareinsights.com
USA: Johnson & Johnson offers USD5.5b to settle talc powder lawsuits - Business and Human Rights Centre
Johnson & Johnson Agrees $5.5bn Settlement To End Baby Powder Cancer Lawsuits - Arise News
J&J's multi-billion-dollar lawsuit: Did India see cancer claims? Is talc banned? - India Today
J&J proposes $5.5B talc baby powder deal over cancer lawsuits - eMarketer
Johnson & Johnson lawsuit: J&J offers up to $5.5 billion to settle baby powder ovarian cancer suits - ABC7 Los Angeles
J&J Proposes $5.5Bn Settlement In Ovarian Talc Litigation - insights.citeline.com
J&J's Proposed $5.5B Settlement Aims to End Talc Litigation - Powder & Bulk Solids
Opinion | The Talc Jackpot Tort Turnaround - WSJ
SETTLEMENT AGREEMENTS—HOUSEHOLD PRODUCTS—Johnson & Johnson proposes $5.5 billion ovarian talc settlement - VitalLaw.com
Here’s how much Johnson & Johnson is offering to settle talc baby powder cancer claims - WSAZ
Johnson & Johnson offers up to $5.5 billion to settle baby powder cancer lawsuits - Gulf Coast News and Weather
J&J proposes $5.5B talc settlement - Endpoints News
Johnson & Johnson offers $5.5B to settle baby powder cancer lawsuits - Global News
Johnson & Johnson agrees to pay $5.5 billion in talc powder settlement - FOX 10 Phoenix
Johnson & Johnson offers $5.5B talc lawsuit settlement - NJBIZ
With $5.5B settlement offer, J&J could be on its way to resolving talc litigation - Fierce Pharma
J&J to Pay $5.5 Billion to Settle Talc-Related Cancer Claims - Bloomberg.com
J&J Aims to End 15-Year Talc Fight With $5.5 Billion Settlement - Bloomberg Law News
$5.5 billion settlement reached in long-running ovarian cancer lawsuit involving Alabama law firm - AL.com
Johnson & Johnson to pay $5.5B to resolve talc litigation - MassDevice
Johnson & Johnson commits $5.5bn to end remaining talc litigation - PMLiVE
Is talcum powder safe? Understanding cancer risks amid Johnson & Johnson lawsuit - The Telegraph
Johnson & Johnson proposes $5.5B settlement to resolve remaining talc litigation - Proactive financial news
Johnson & Johnson offers to pay up to $5.5 billion to settle baby powder lawsuit - gamereactor.eu
Johnson & Johnson's talc settlement ends one fight. The casualty market's bigger problem remains - Insurance Business
Is J&J approaching the end of its talc litigation hangover? - pharmaphorum
Cosmetics giant to pay billions in baby powder lawsuit settlements - independent.co.uk
J&J's $5.5 Billion Talc Settlement Has a Catch: 95% of Plaintiffs Must Say Yes - The Legal Examiner
Johnson & Johnson is paying $5.5 billion to settle its baby powder cancer lawsuits - qz.com
$5.5B J&J talc deal could end decade-long legal battle - The Hill
Jim Cramer: J&J talc settlement is good for a stock that has so much going for it already - CNBC
Johnson & Johnson Offers $5.5 Billion Settlement For Talcum Powder Lawsuits - NDTV
Johnson & Johnson settlement nets payments for thousands - NJ.com
Johnson & Johnson proposes $5.5 billion talc settlement to end marathon legal fight - AP News
Johnson & Johnson to pay $5.5bn settlement in talc cancer lawsuit - The Guardian
Johnson & Johnson offers up to $5.5bn to settle baby powder lawsuits - BBC
Johnson & Johnson agrees to pay $5.5B to settle talc lawsuits - Fox Business
J&J reaches sweeping talc deal that could end decade of litigation - Reuters
Johnson & Johnson reaches proposed $5.5B talcum powder settlement - upi.com
Johnson & Johnson offers $5.5 billion to settle talc lawsuits - cbsnews.com
Johnson & Johnson to pay $5.5 billion to settle baby powder cancer lawsuits - India Today
J&J offers $5.5bn to settle baby powder lawsuits - Sky News
Johnson & Johnson offers $5.5bn to settle talc cancer lawsuits - Al Jazeera
J&J, Ovarian Cancer Talc Claimants Unveil $5.5B Global Deal - law360.com
J&J announces $5.5bn settlement of talc lawsuits - RTE.ie
Johnson & Johnson reaches proposed $5.5B settlement to resolve talc lawsuits tied to ovarian cancer claims - Anadolu Ajansı
Johnson & Johnson announces US$5.5bil settlement of talc lawsuits - Free Malaysia Today
Johnson & Johnson Settles 76,000 Talcum Powder Lawsuits for at Least $5.5B - Law.com
Johnson & Johnson announces $5.5 billion settlement of talc lawsuits - Yahoo! Finance Canada
Johnson & Johnson Announces a Proposed Resolution of Ovarian Talc Litigation - Business Wire
Johnson & Johnson to pay up to $5.5B to settle talc lawsuits (JNJ:NYSE) - Seeking Alpha
Johnson & Johnson to pay $5.5bn to settle US talcum powder lawsuit - Financial Times
Johnson & Johnson Agrees to Pay $5.5 Billion to Settle Talc Lawsuits - WSJ
Federal Judge Casts Doubt on 69,000 Cases Alleging J&J Talc Caused Cancer - Insurance Journal
Massive Awards in J&J Mesothelioma Talc Lawsuits as New Cases Filed - The Legal Examiner
US judge casts doubt on 69,000 cases alleging J&J talc caused cancer - Free Malaysia Today
Johnson & Johnson Wins Big: Federal Judge Orders Nearly 70,000 Talc Claimants to Show Why They Shouldn't be Dismissed - Law.com
After Disqualifying Beasley Allen, Johnson & Johnson Sets Sights on Other Talc Lawyers - Law.com
Court OKs $45M verdict in talc asbestos case, including $30M for ‘reduced lifespan’ - The Black Chronicle
'Stunning Turn of Events': Johnson & Johnson Asks Judge to Order Potential Dismissal of All 67,000 Talc Lawsuits - Law.com
Retired judge urges federal court to reject key talc researcher’s testing - The Black Chronicle
Johnson & Johnson (JNJ) Stock May Be Reasonable After Talc Verdict Ruling - Yahoo Finance
Can Johnson & Johnson (JNJ) Trade At A Discount Despite Talc Risk? - simplywall.st
Ill. Appeals Court Upholds $45M Talc Verdict Against J&J - Law360
Johnson & Johnson (JNJ) Faces Upheld $45 Million Talc Verdict In Illinois - simplywall.st
Johnson & Johnson (JNJ) Faces Fresh Talc Risk After $45 Million Verdict Stands - Yahoo Finance
Johnson's talcum powder found in Adamstown cupboard to be tested for asbestos - Newcastle Herald
Pa. Superior Court Upholds J&J Win In Talc Cancer Suit - Law360
Scottish court approves group legal action against Johnson & Johnson over talcum powder - Global Cosmetics News
Johnson & Johnson (JNJ) Has a Diversified Earnings Engine Bigger Than Talc - AlphaStreet
Court approves Scottish group action over Johnson & Johnson baby powder - Scottish Legal News
Why Minerals Technologies (MTX) Is Down 6.7% After Establishing a US$450 Million Talc Injury Trust - Sahm
J&J cleared in talc-related cancer lawsuit in California - MSN
Johnson & Johnson (JNJ) Expands Cancer Pipeline As Talc Verdict Eases One Risk - Yahoo Finance
Block Drug Company & Asbestos Exposure - Mesothelioma.com
Minerals Technologies Files Talc Litigation Reorganization Plan - TipRanks
Johnson & Johnson (JNJ) Beats Lawsuit Alleging that Talc caused Three Women’s Cancer - Yahoo Finance
Talc Lawsuits | Cancer Patients Appeal Revlon Bankruptcy - Mesothelioma.com
High Court Throws Out Baby Powder Ban - Parents Africa
Kenyan court halts ban of Johnson and Johnson baby powder - Businessfront
Mesothelioma Lawsuit (July Update) - Oberheiden P.C.
High Court rejects attempt to ban Johnson & Johnson baby powder - Business Daily
After Experts Withdrawn, J&J Wants Ovarian Cancer Talc MDL Dismissed - Mealey's
New study identifies the makeup brands with the highest potential asbestos risk - ConsumerAffairs
Maybelline & Asbestos Exposure - Mesothelioma.com
Case management judgment in Fuschillo and ors v Johnson & Johnson - Signature Litigation
Why Some J&J Talc Ovarian Cancer Lawsuits Win Millions - The Legal Examiner
Why Some J&J Talc Ovarian Cancer Lawsuits Win Millions While Others Lose - The Legal Examiner
J&J Can't Get New Trial In $65.5M Minn. Talc Cancer Case - Law360
Critical Mass With Law.com’s Amanda Bronstad: Judge in $4B Sex Abuse Settlement Probes Lawyers Over Possible Fraud, LA Juries Hit J&J With $32M Talc Verdict and a Mistrial - Law.com
Avon Products files for bankruptcy following cash flow issues caused by talc lawsuits - British Beauty Council
California Woman Receives $32 Million Judgment in Johnson & Johnson Mesothelioma Lawsuit - Mesothelioma Guide
J&J Fails To Undo $65.5M Verdict In Minn. Talc Cancer Case - Law360
J&J Talc Trial In LA Ends With Deadlocked Jury - Law360
Woman Wins $32 Million in Johnson & Johnson Lawsuit - Mesothelioma Guide
J&J Wants Talc MDL Tossed After Plaintiffs Withdraw Experts - Law360
J&J Moves to Shed Cases Claiming Talc Products Caused Cancer - Bloomberg Law News
Litigators of the Week: After 6-Week, 3-Plaintiff Trial in Second Calif. Talc Bellwether, a Defense Verdict for J&J - Law.com
J&J faces $32M jury award over talc-linked cancer case (update) - Seeking Alpha
J&J faces $32M jury award over talc-related cancer case (JNJ) - Seeking Alpha
Jury awards $32M in asbestos talc case against J&J By Investing.com - Investing.com Canada
Los Angeles Jury Awards $32M in Talc Trial Against Johnson & Johnson - Law.com
J&J Talc Claimants Win OK For UK Group Asbestos Suit - Law360
Talc Verdict Tests Johnson & Johnson Balance Of Legal Risk And Growth - Yahoo Finance
J&J hit with $32M jury award in LA over talc-related cancer case - Seeking Alpha
Johnson & Johnson Hit with $32 Million Verdict in Los Angeles Asbestos Trial - Yahoo Finance
J&J Notches Defense Win At Key Cosmetic Talc Bellwether Trial: Watch Gavel-to-Gavel via CVN - CVN News
Johnson & Johnson wins ovarian cancer talc lawsuit in California - Global Cosmetics News
Los Angeles jury sides with Johnson & Johnson in bellwether talc trial - The Black Chronicle
Court rules for Johnson and Johnson in talc lawsuit, plaintiffs fail to prove causation - mezha.net
J&J beats lawsuit alleging talc caused cancer in three women - Maryland Daily Record
Johnson & Johnson beats talc lawsuit in California court case - Cosmetics Business
Claimants press for resolution as Barretts talc bankruptcy fight nears key date - NBC Montana
Talc Ovarian Cancer: J&J Wins Crucial US Jury Verdict - OC Academy
J&J wins talc cancer lawsuit as jury rejects negligence claims - Indianweekender
Johnson & Johnson Wins Talc Powder Lawsuit Amid Ongoing Legal Ba - GuruFocus
J&J wins talc-related cancer case in California (JNJ:NYSE) - Seeking Alpha
Johnson & Johnson beats lawsuit alleging that talc caused 3 women’s cancer - The Straits Times
J&J beats lawsuit alleging that talc caused three women’s cancer By Reuters - Investing.com
Johnson & Johnson beats lawsuit alleging that talc caused three women's cancer - The Economic Times
J&J Cleared in Talc Cancer Lawsuit - Devdiscourse
BREAKING: J&J Cleared Of Talc Liability In LA Bellwether Trial - Law360
Johnson & Johnson Wins Los Angeles Talc Cancer Trial; Jury Finds No Negligence - News and Statistics - IndexBox
J&J Beats Lawsuit Alleging That Talc Caused Three Women's Cancer - U.S. News - Money
J&J Cleared in Talc Cancer Lawsuit: A Major Legal Victory - Devdiscourse
J&J Talc Unit Settles Committee Fee Tiff With Paul Hastings - Law360
J&J Cleared Of Talc Liability In LA Bellwether Trial - Law360
Johnson & Johnson Scores Defense Verdict in 2nd Talc Bellwether in Los Angeles Superior Court - Law.com
J&J beats lawsuit alleging that talc caused three women's cancer - Yahoo Finance
Talc Trial Opens Against J&J Over Retired Florida Doc's Ovarian Cancer Death - CVN News
Talc Lawyers Ask Los Angeles Jury to Hit Johnson & Johnson With Punitive Damages: 'The Language They Speak Is Money' - Law.com
No 'Conspiracy To Hide Asbestos' In Talc, J&J Atty Tells Jury - Law360
'This Is Their Document:' Jury Told J&J Docs Prove Talc Lies - Law360
$10.2 Million Verdict Names Popular Brands Sold at Walgreens, Walmart - Mesothelioma Guide
Talc Tester Says J&J Never Pressured Him To Hide Asbestos - Law360
Ga. Panel Says New Trial Warranted In J&J Talc Cancer Suit - Law360
Defense Win in Phila.'s First Talc Trial Stands as Appellate Court Rejects Challenges - Law.com
Johnson & Johnson Wins Talc Verdict in Oklahoma, Appeal in Pennsylvania - Law.com
J&J Gets Trial Win In Oklahoma Talc Mesothelioma Case - Law360
Beasley Allen Fails To Overturn J&J Talc Disqualification - Law360
Merck Talc Verdict Adds Fresh Liability Question For High Flying Shares - Yahoo Finance
Merck Faces Talc Verdict Questions For Future Legal And Earnings Risks - simplywall.st
Talc Use Blamed in Nearly Half of Asbestos Claims - Mesothelioma Guide
Assessing Johnson & Johnson (JNJ) Valuation After Guidance Raise Growth Initiatives And Talc Litigation Update - Yahoo Finance
Talc Blamed for Nearly Half of Asbestos Exposure Lawsuits in 2025 - Mesothelioma Guide
Johnson And Johnson Faces Minnesota Talc Verdict As Valuation Discount Persists - Yahoo Finance
Did New Talc Verdict and MedTech Launch Just Shift Johnson & Johnson's (JNJ) Investment Narrative? - simplywall.st
J&J 's 'Pure' Baby Powder Ads Were Pure Lies, Jury Told - Law360
Anoka County Couple Wins $10.2M Talc Verdict - Hoodline
Jury Awards $10.2M Verdict in Case Tying Cancer to Asbestos-Laced Talc - Law.com
Prof. Hired By J&J In 1970s Found Asbestos In Talc, Jury Told - Law360
Toxicologist Denies J&J Wanted To 'Control' Talc Study - Law360
Comic Gets Serious About Mom's Cancer At J&J Talc Trial - Law360
J&J Willing To Pay $8.9B To Settle Talc Lawsuits (B56fd2sshn) - Fathom Journal
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology • O'Brien KM • PMID 42578967 • Journal Article.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer • Yu H • PMID 42552036 • Editorial.
Annals of work exposures and health • Mischler SE • PMID 42497380 • Journal Article.
Inhalation toxicology • Wylie AG • PMID 42363609 • Journal Article.
Medicine, science, and the law • Taioli E • PMID 42300360 • Journal Article.
No recent FDA signals. Monitoring is active — this section updates automatically.
Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation
PACER docket filed in JPML: The plaintiffs are suing Johnson & Johnson and associated entities, alleging that their talcum powder products, specifically Johnson & Johnson’s Baby Powder and Shower to Shower, were defective and caused various injuries. These injuries include personal and economic losses, as well as physical and
Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation
PACER docket entry from NJD: COMPLAINT against JANSSEN PHARMACEUTICALS INC., JOHNSON & JOHNSON, JOHNSON & JOHNSON CONSUMER INC., JOHNSON & JOHNSON HOLDCO (NA), INC., KENVUE, INC., LLT MANAGEMENT, LLC, RED RIVER TALC, LLC ( Filing and Admin fee $ 405 receipt number ANJDC-17765490) with JURY DEMAND, filed by MARY BERTIE. (Attachm
Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation
PACER docket entry from NJD: COMPLAINT against JANSSEN PHARMACEUTICALS INC., JOHNSON & JOHNSON, JOHNSON & JOHNSON CONSUMER INC., JOHNSON & JOHNSON HOLDCO (NA) INC., KENVUE INC., LLT MANAGEMENT, LLC, RED RIVER TALC LLC ( Filing and Admin fee $ 405 receipt number ANJDC-17765178) with JURY DEMAND, filed by SHERRY BENNETT. (Attachm
Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation
PACER docket entry from NJD: COMPLAINT against JANSSEN PHARMACEUTICALS, INC., JOHNSON & JOHNSON, JOHNSON & JOHNSON CONSUMER, INC., JOHNSON & JOHNSON HOLDCO (NA) INC., KENVUE, INC., RED RIVER TALC, LLC ( Filing and Admin fee $ 405 receipt number ANJDC-17762929) with JURY DEMAND, filed by DAVID FITZSIMMONS, SR. (Attachments: # 1
Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation
PACER docket entry from NJD: COMPLAINT against JANSSEN PHARMACEUTICALS, INC., JOHNSON & JOHNSON, JOHNSON & JOHNSON CONSUMER, INC., JOHNSON & JOHNSON HOLDCO (NA) INC., KENVUE, INC., RED RIVER TALC, LLC ( Filing and Admin fee $ 405 receipt number BNJDC-17762707) with JURY DEMAND, filed by LINDA SULLIVAN. (Attachments: # 1 Civil C
Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation
PACER docket entry from FLSD: NOTICE OF REMOVAL (STATE COURT COMPLAINT - Belen Pinero v. Johnson & Johnson, et al.) Filing fee $ 405.00 receipt number AFLSDC-19834658, filed by Johnson & Johnson Consumer, Inc., Johnson & Johnson Inc.. (Attachments: # 1 Civil Cover Sheet, # 2 Exhibit A- State Court Complaint and Other State Court
Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation
PACER docket entry from NJD: COMPLAINT against JANSSEN PHARMACEUTICALS, INC., JOHNSON & JOHNSON, JOHNSON & JOHNSON CONSUMER, INC., JOHNSON & JOHNSON HOLDCO (NA) INC. (NEW JJCI), KENVUE, INC., RED RIVER TALC LLC ( Filing and Admin fee $ 405 receipt number ANJDC-17739281) with JURY DEMAND, filed by THERESA BURTON. (Attachments: #
Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation
PACER docket entry from NJD: COMPLAINT against JANSSEN PHARMACEUTICALS, INC., JOHNSON & JOHNSON, JOHNSON & JOHNSON CONSUMER, INC., JOHNSON & JOHNSON HOLDCO (NA) INC. (NEW JJCI), KENVUE, INC., RED RIVER TALC LLC ( Filing and Admin fee $ 405 receipt number ANJDC-17739103) with JURY DEMAND, filed by CYNTHIA BELZ. (Attachments: # 1
Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation
PACER docket entry from NJD: COMPLAINT against JANSSEN PHARMACEUTICALS, INC., JOHNSON & JOHNSON, JOHNSON & JOHNSON CONSUMER, INC., JOHNSON & JOHNSON HOLDCO (NA) INC. (NEW JJCI), KENVUE, INC., RED RIVER TALC LLC ( Filing and Admin fee $ 405 receipt number ANJDC-17738647) with JURY DEMAND, filed by WYNN DUVERNAY. (Attachments: #
Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation
PACER docket entry from NJD: COMPLAINT against All Defendants ( Filing and Admin fee $ 405 receipt number ANJDC-17737967) with JURY DEMAND, filed by MATILDE LUPO. (Attachments: # 1 Civil Cover Sheet Civil Cover Sheet)(CRONEN, LESLIE) (Entered: 07/31/2026)
Workbench
Sign in to save litigations, capture notes, and monitor live signals. Sign in for unlimited.
LexGenius Ranking
88Score
Court, news, and regulatory activity are elevated
Monitoring
Live
monitoring
Last: Aug 12, 2026, 2:00 AM UTC
Next: —
Source Monitoring
PACER
PACER
Google News
FAERS
PubMed
Event feed
427
events detected
AI Brief
Talc remains late-stage / active trials with 427 current signals in the accepted feed.
Overview
Johnson & Johnson announced a $5.5 billion settlement July 27, 2026, to resolve approximately 76,000 ovarian cancer claims across MDL-2738 and state courts. The deal follows a July 22, 2026 order by Magistrate Judge Rukhsanah L. Singh requiring plaintiffs to show cause why remaining claims should not be dismissed after plaintiffs withdrew two specific-causation experts. District Judge Michael A. Shipp presides over MDL-2738 in the District of New Jersey. The settlement requires 95% participation to take effect.
Key developments
PACER court filing on Dec 31: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation. ‖ RTE.ie news on Aug 9: Money talcs: Why J&J offered $5.5bn to end cancer cases - RTE.ie. ‖ PubMed research on Aug 11: Personal Talc Use and Incident Lung Cancer..
Generated Aug 12, 2026, 2:00 AM UTC
Tracked MDLs
MDL 2738
D.N.J.
Johnson & Johnson talcum powder products liability